Quoin Pharmaceuticals. Ltd Sponsored ADR
(NASDAQ: QNRX)

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

18.910

+1.085 (+6.09%)
Range 17.460 - 18.910   (8.30%)
Open 17.740
Previous Close 17.825
Bid Price 0.449
Bid Volume -
Ask Price 0.450
Ask Volume -
Volume 15,791
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events


Top Contributors

JonWick38 avatar
11359
Followers 272
Posts 2459

Loading Chart...

Please login to view stock data and analysis